Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) is projected to post its Q3 2025 results before the market opens on Friday, October 10th. Get Nurix Therapeutics alerts:Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) last posted its earnings results on Wednesday, July 9th. On average, analysts expect Nurix Therapeutics to post $-3 EPS for the current fiscal year and $-3 EPS for the next fiscal year. Nurix Therapeutics Price PerformanceNASDAQ NRIX opened at $9.08 on Friday. Featured StoriesReceive News & Ratings for Nurix Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nurix Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.